AB002. SOH24AB_126. Qualitative and quality of life study exploring the patient’s perspective in a case of robot-assisted radical cysto-prostatectomy and intra-corporeal neo-bladder for the treatment of bladder cancer
Video Session

AB002. SOH24AB_126. Qualitative and quality of life study exploring the patient’s perspective in a case of robot-assisted radical cysto-prostatectomy and intra-corporeal neo-bladder for the treatment of bladder cancer

Clare Chadda, Adrian Cham, Mohamed Zeid, Subhasis Giri

Department of Urology & Robotic Surgery, University Hospital Limerick, St Nessan’s Road, Dooradoyle, Limerick, Ireland


Background: Bladder cancer (BC) patients who undergo radical cystectomy (RC) and urinary diversion (UD) encounter functional and quality-of-life (QoL) challenges. Little is known about patient’s experiences from diagnosis, decision-making, surgery, and recovery, or how they can vary by treatment setting. Minimally invasive robot-assisted RC and UD has potential to minimise physical and psychological trauma and are increasingly being adopted for patient with muscle invasive bladder cancer (MIBC) world-wide. This study aims to report QoL and experience of a patient who underwent robot-assisted radical cysto-prostatectomy and intra-corporeal neo-bladder (RRCINB) for the treatment of MIBC and to explore patient’s journey from diagnosis, per-operative care and effect on QoL.

Methods: We describe our patient’s journey through presentation, diagnostic tests, and initial transurethral resection of bladder tumour (TURBT) for staging, decision making process for RRCINB and post-operative recovery. Semi-structured interview and various relevant QoL questionnaires were used.

Results: A 65-year-old gentleman presented with visible haematuria and following initial investigation and TURBT, MIBC was diagnosed. The patient was extensively counselled about diagnosis and treatment options such as neo-adjuvant chemotherapy followed by open vs. robotic radical cysto-prostatectomy and ileal conduit vs. neo-bladder formation. The patient opted for RRCINB without neo-adjuvant chemotherapy. His journey was detailed in our report and QoL experiences were documented using International Prostate Symptom Score (IPSS), 36-Item Short Form (SF-36) and International Index of Erectile Function (IIEF) questionnaire.

Conclusions: Information to support patient affected by BC in several aspects of their life trajectory (e.g., shared decision-making and self-management of their UD) was most important throughout the interviews. This study provides an in-depth patient’s journey after diagnosis of BC and QoL outcome RRCINB and can be used for counselling of patients with BC.

Keywords: Bladder cancer (BC); robotic surgery; intra-corporeal urinary diversion (intra-corporeal UD); orthotopic neobladder; intracorporeal neobladder robotic urinary diversion (intracorporeal neobladder robotic UD); robotic cystoprostatectomy


Acknowledgments

Funding: None.


Footnote

Conflicts of Interest: The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


doi: 10.21037/map-24-ab002
Cite this abstract as: Chadda C, Cham A, Zeid M, Giri S. AB002. SOH24AB_126. Qualitative and quality of life study exploring the patient’s perspective in a case of robot-assisted radical cysto-prostatectomy and intra-corporeal neo-bladder for the treatment of bladder cancer. Mesentery Peritoneum 2024;8:AB002.

Download Citation